Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Commentaries

Clocking Up GLP-1: Considering Intestinal Rhythms in the Incretin Effect

  1. Frank Reimann⇑ and
  2. Akhilesh B. Reddy
  1. Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.
  1. Corresponding author: Frank Reimann, fr222{at}cam.ac.uk.
Diabetes 2014 Nov; 63(11): 3584-3586. https://doi.org/10.2337/db14-0781
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Pancreatic β-cells, like many other cells, contain autonomous circadian oscillators, the disruption of which leads to hypoinsulinemia and hyperglycemia in mice (1,2). Rather than slavishly following the master clock located in the suprachiasmatic nuclei, which synchronize internal oscillations with the external light-dark cycle, some peripheral clocks, including the one in the endocrine pancreas, can be reset by alternative clues, such as time-restricted food availability. The way that this food “entrainment” works has remained unclear. GLP-1, an incretin hormone that boosts glucose-dependent insulin secretion, is a candidate messenger that could potentially coordinate peripheral oscillators with the timing of food arrival in the gut. In this issue of Diabetes, Gil-Lozano et al. (3) investigated the influence of the day-night cycle on the GLP-1 axis.

To circumvent interference from previous meals, Gil-Lozano et al. fasted rats for 4 h before applying oral glucose tolerance tests (OGTTs) at intervals throughout the day. They observed clear 24-h rhythmicity of plasma GLP-1 concentrations that were in phase with insulin levels. Interestingly, the strongest responses were observed toward the end of the lights-on period—a time when nocturnal rats allowed to consume food freely do not usually eat much. The circadian rhythm of plasma glucose responses had a higher frequency, possibly reflecting the 12-h period reported for hepatic metabolic cycles (4).

To test if the observed diurnal rhythm of GLP-1 responses was food entrainable, rats were accustomed to feed only during the dark or the light phase. Dark-fed rats, like their free-feeding counterparts, had a more pronounced GLP-1 response at the end of the light phase, consistent with the normal nocturnal feeding pattern of ad libitum–fed rats. Importantly, however, light-fed animals showed a clear reversal of the responsiveness, with greater GLP-1 responses appearing at the end of the dark phase and a parallel reversal of the insulin profile. Somewhat surprisingly, increased GLP-1 and insulin responses did not translate into lower glucose concentrations, but additional factors such as the rates of intestinal glucose absorption and hepatic gluconeogenesis also could influence plasma glucose profiles.

Indeed, glucose absorption from the intestine is dependent on sodium-glucose transporter 1 (SGLT1), whose expression and function is known to show a circadian rhythm that normally peaks at the end of the light phase in rats but shifted ∼8 h when food access was restricted to the lights-on period (5). The peak expression of SGLT1 at the end of the light phase in ad libitum– and dark-fed rats (5) corresponds well with the more rapid rise of plasma glucose at this time seen by Gil-Lozano et al. As SGLT1 underlies glucose-sensing in GLP-1 secreting L cells (6), its rhythmicity also may contribute to the correspondingly enhanced GLP-1 responses.

A counterintuitive relationship between plasma glucose and the GLP-1 profile also was observed in dark-fed adapted animals deprived of external cues by their exposure to constant light. These animals were relatively glucose intolerant at “nighttime,” compared with dark-fed animals experiencing normal light-dark cycles. These experiments are, however, difficult to interpret, as small mammals can exhibit different individual behavioral responses to constant light. Some become arrhythmic or retain some rhythmicity with lengthened periods, whereas others show a phenomenon known as splitting, in which two periods of increased activity with drifting times of onset occur during each 24-h period (7,8). It should also be noted that restricting food access to just 4 or 6 h daily in the middle of the lights-on phase has previously been reported to result in an anticipatory transient elevation of plasma GLP-1 ∼1 h before the reintroduction of food (9,10). No attempts were made to link these observations to a circadian rhythm, but the results suggest that food restriction has effects beyond resetting the intestinal clock and the responsiveness of enteroendocrine L cells to glucose.

Gil-Lozano et al. investigated the intracellular mechanisms underlying circadian responsiveness in L cells, using the GLUTag cell line. Serum starvation of these model L cells combined with a brief stimulation with the adenylate cyclase activator forskolin resulted in synchronized oscillations of the clock genes Bmal1, Per2, and Rev-Erbα over the following 48 h. These genes normally maintain a 24-h periodicity through opposing negative and positive feedback loops (11,12), as illustrated in Fig. 1. In GLUTag cells, Bmal1 expression peaked 4 h after synchronization, while Rev-Erbα and Per2 were expressed at higher levels 16 h after the forskolin shock. Secretory responses to the muscarinic agonist bethanechol fluctuated approximately in phase with Bmal1, and responses to a number of other stimuli were similarly enhanced at 4 h, but largely absent 16 h, after synchronization. Expression of proglucagon, the precursor of GLP-1, was enhanced within the first 24 h after forskolin treatment, in line with previous reports (13), but fell during the subsequent day without an obvious circadian rhythm. Regulation of the proglucagon gene therefore would be unlikely to underlie the rhythmicity of GLP-1 secretory responses.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

L cells are stimulated by nutrient arrival in the intestinal lumen to secrete GLP-1. The responsiveness of L cells has a diurnal rhythm kept by the canonical mammalian clock. This consists of transcriptional loops, in which the transcriptional activator complex BMAL1/CLOCK promotes expression of the period (e.g., Per2) and cryptochrome (Cry) genes and the orphan nuclear receptor genes Rev-Erbα and Rorα. Once translated, the PER/CRY protein heterodimer inhibits BMAL1/CLOCK activity, while REV-ERBα and RORα inhibit and promote Bmal1 transcription, respectively. The phase of this clock, usually synchronized with the light-dark cycle through signals from a similar molecular clock in the suprachiasmatic nucleus, is itself reset by food availability and affects secretory responses to a range of stimuli, at least in part by Tef and Prl1 activity.

Interestingly, knockout of Bmal1 in pancreatic β-cells has been shown to interfere with insulin secretion distal to glucose-induced membrane depolarization and elevation of cytosolic Ca2+, possibly affecting vesicular trafficking and/or fusion (1). More recently, clock genes have been linked to NAD+ and sirtuin activity oscillations in hepatocytes (14), and it has been speculated that this might link the cellular clock to later stages of hormone secretion (15). Gil-Lozano et al. concentrated on two other genes, namely the transcription factor thyrotroph embryonic factor (Tef) and protein tyrosine phosphatase 4a1 (also known as phospatase of regenerating liver-1 [PRL-1]), which were differentially expressed 4 and 16 h after synchronization in GLUTag cells. They further showed that knockdown of these two candidates at the time of their respective peak expression levels affected responses to a number of secretagogues. The possible mechanisms linking these genes to GLP-1 secretion need to be investigated in future experiments to fully consolidate this aspect of the authors’ work.

In summary, Gil-Lozano et al. (3) have established that a diurnal rhythm underlies GLP-1 secretion. As the central and peripheral GLP-1 axes exert independent effects on food intake (16), it will be interesting to establish whether brain stem GLP-1–secreting neurons also exhibit a diurnal activity pattern. How the current findings relate to the reported association of metabolic disease and shift work (17) and the potential implications for the use of once-daily or once-weekly GLP-1 mimetics (18) for the treatment of diabetes will be fascinating areas for future research.

Article Information

Funding. Research in F.R.’s laboratory is currently primarily funded by a Wellcome Trust grant (WT084210/Z/07/Z) and the MRC (Metabolic Diseases Unit). Research in A.B.R.’s laboratory is funded by the Wellcome Trust (100333/Z/12/Z), the European Research Council (MetaCLOCK 281348), and the Lister Institute of Preventive Medicine.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Footnotes

  • See accompanying article, p. 3674.

  • © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

References

  1. ↵
    1. Marcheva B,
    2. Ramsey KM,
    3. Buhr ED,
    4. et al
    . Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010;466:627–631
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Sadacca LA,
    2. Lamia KA,
    3. deLemos AS,
    4. Blum B,
    5. Weitz CJ
    . An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. Diabetologia 2011;54:120–124
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Gil-Lozano M,
    2. Mingomataj EL,
    3. Wu WK,
    4. Ridout SA,
    5. Brubaker PL
    . Circadian secretion of the intestinal hormone GLP-1 by the rodent L cell. Diabetes 2014;63:3674–3685
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Cretenet G,
    2. Le Clech M,
    3. Gachon F
    . Circadian clock-coordinated 12 hr period rhythmic activation of the IRE1alpha pathway controls lipid metabolism in mouse liver. Cell Metab 2010;11:47–57
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Balakrishnan A,
    2. Stearns AT,
    3. Ashley SW,
    4. Tavakkolizadeh A,
    5. Rhoads DB
    . Restricted feeding phase shifts clock gene and sodium glucose cotransporter 1 (SGLT1) expression in rats. J Nutr 2010;140:908–914
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Reimann F,
    2. Habib AM,
    3. Tolhurst G,
    4. Parker HE,
    5. Rogers GJ,
    6. Gribble FM
    . Glucose sensing in L cells: a primary cell study. Cell Metab 2008;8:532–539
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Cheung PW,
    2. McCormack CE
    . Splitting of the locomotor activity rhythm in rats by exposure to continuous light. Am J Physiol 1983;244:R573–R576
    OpenUrl
  8. ↵
    1. Ohta H,
    2. Yamazaki S,
    3. McMahon DG
    . Constant light desynchronizes mammalian clock neurons. Nat Neurosci 2005;8:267–269
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Vahl TP,
    2. Drazen DL,
    3. Seeley RJ,
    4. D’Alessio DA,
    5. Woods SC
    . Meal-anticipatory glucagon-like peptide-1 secretion in rats. Endocrinology 2010;151:569–575
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Dailey MJ,
    2. Stingl KC,
    3. Moran TH
    . Disassociation between preprandial gut peptide release and food-anticipatory activity. Endocrinology 2012;153:132–142
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Reddy AB,
    2. Rey G
    . Metabolic and nontranscriptional circadian clocks: eukaryotes. Annu Rev Biochem 2014;83:165–189
    OpenUrlCrossRefPubMed
  12. ↵
    1. Wu L,
    2. Reddy AB
    . Rethinking the clockwork: redox cycles and non-transcriptional control of circadian rhythms. Biochem Soc Trans 2014;42:1–10
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Brubaker PL,
    2. Schloos J,
    3. Drucker DJ
    . Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 1998;139:4108–4114
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Peek CB,
    2. Affinati AH,
    3. Ramsey KM,
    4. et al
    . Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 2013;342:1243417
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Peek CB,
    2. Ramsey KM,
    3. Marcheva B,
    4. Bass J
    . Nutrient sensing and the circadian clock. Trends Endocrinol Metab 2012;23:312–318
    OpenUrlCrossRefPubMed
  16. ↵
    1. Williams DL,
    2. Baskin DG,
    3. Schwartz MW
    . Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 2009;150:1680–1687
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Pan A,
    2. Schernhammer ES,
    3. Sun Q,
    4. Hu FB
    . Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med 2011;8:e1001141
    OpenUrlCrossRefPubMed
  18. ↵
    1. Buse JB,
    2. Nauck M,
    3. Forst T,
    4. et al
    . Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study. Lancet 2013;381:117–124
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Diabetes: 63 (11)

In this Issue

November 2014, 63(11)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clocking Up GLP-1: Considering Intestinal Rhythms in the Incretin Effect
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Clocking Up GLP-1: Considering Intestinal Rhythms in the Incretin Effect
Frank Reimann, Akhilesh B. Reddy
Diabetes Nov 2014, 63 (11) 3584-3586; DOI: 10.2337/db14-0781

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Clocking Up GLP-1: Considering Intestinal Rhythms in the Incretin Effect
Frank Reimann, Akhilesh B. Reddy
Diabetes Nov 2014, 63 (11) 3584-3586; DOI: 10.2337/db14-0781
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Going in Early: Hypoxia as a Target for Kidney Disease Prevention in Diabetes?
  • There Is Something About Insulin Granules
  • Metabolic Flexibility of Mitochondria Plays a Key Role in Balancing Glucose and Fatty Acid Metabolism in the Diabetic Heart
Show more Commentaries

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.